氟西汀联合奥昔布宁对肺癌合并焦虑障碍患者的精神症状与生活质量的改善作用研究
A Study on the Improvement of Psychiatric Symptoms and Quality of Life in Patients with Lung Cancer and Anxiety Disorder with Fluoxetine and Oxybutynin
DOI: 10.12677/acm.2025.15113218, PDF,    科研立项经费支持
作者: 蔡政忠:广州理工学院工商管理学院,广东 广州;钟 燕*:成都市第七人民医院目标办,四川 成都;林嗣豪:莆田学院管理学院医疗健康产业管理系,福建 莆田
关键词: 氟西汀奥昔布宁肺癌焦虑障碍生活质量Fluoxetine Oxybutynin Lung Cancer Anxiety Disorder Quality of Life
摘要: 目的:探讨氟西汀联合奥昔布宁对肺癌合并焦虑障碍患者精神症状与生活质量的改善作用及安全性。方法:选取2023年1月~2024年1月在本院收治的肺癌合并焦虑障碍患者60例,采用随机数字表法分为研究组与对照组,各30例。对照组提供氟西汀单药治疗,研究组在此基础上加用奥昔布宁,疗程均为12周。对比一般肺癌患者精神症状、生活质量、不良反应发生状况。结果:干预前,两组HADS-A、HADS-D及QLQ-C30评分比较差异无统计学意义(P > 0.05);干预12周后,研究组HADS-A、HADS-D评分均显著低于对照组(P < 0.05),QLQ-C30总体健康状况评分显著高于对照组(P < 0.05)。研究组不良反应发生率为16.67% (5/30),对照组为13.33% (4/30),差异无统计学意义(P > 0.05)。结论:氟西汀联合奥昔布宁可有效改善肺癌合并焦虑障碍患者的精神症状,提升生活质量,且安全性良好,值得推广。
Abstract: Objective: To explore the efficacy and safety of fluoxetine combined with oxybutynin in improving mental symptoms and quality of life of patients with lung cancer complicated with anxiety disorder. Methods: Sixty patients with lung cancer complicated with anxiety disorder admitted to our hospital from January 2023 to January 2024 were randomly divided into a study group and a control group, with 30 cases in each group. The control group was given fluoxetine alone, and the study group was given oxybutynin on the basis of it. The course of treatment was 12 weeks. To compare the mental symptoms, quality of life and adverse reactions of general lung cancer patients. Results: Before the intervention, there was no significant difference in the scores of HADS-A, HADS-D and QLQ-C30 between the two groups (P > 0.05). After 12 weeks of intervention, the HADS-A and HADS-D scores of the study group were significantly lower than those of the control group (P < 0.05), and the overall health status score of QLQ-C30 was significantly higher than that of the control group (P < 0.05). The incidence of adverse reactions was 16.67% (5/30) in the study group and 13.33% (4/30) in the control group, with no statistical significance (P > 0.05). Conclusion: Fluoxetine combined with oxybutynin can effectively improve the mental symptoms and improve the quality of life of patients with lung cancer complicated with anxiety disorder, and it is safe and worth popularizing.
文章引用:蔡政忠, 钟燕, 林嗣豪. 氟西汀联合奥昔布宁对肺癌合并焦虑障碍患者的精神症状与生活质量的改善作用研究[J]. 临床医学进展, 2025, 15(11): 1262-1267. https://doi.org/10.12677/acm.2025.15113218

参考文献

[1] 蔡政忠, 郑凤颦. 大鼠强迫症模型的建立与解除——以喹吡罗, 氯丙咪嗪交叉使用为例[J]. 中国医学人文, 2024, 10(13): 35-36.
[2] 蔡政忠, 郑凤颦. 多巴胺受体激动剂构建精神分裂动物模型实验[J]. 医师在线, 2024, 11(13): 22-23.
[3] 蔡政忠, 郑凤颦. 谷氨酸应用于大鼠精神分裂症的模型构建[J]. 健康世界, 2024, 32(13): 18-19.
[4] 蔡政忠, 郑凤颦. 间氯苯基哌嗪诱导囓齿类动物强迫行为的模型分析[J]. 护理前沿, 2024, 6(13): 11-12.
[5] 蔡政忠, 林嗣豪. 社交与性交神经环路的人兽试验——以卡麦角林调控催产素与多巴胺中枢神经通路为例[J]. 中国医学人文, 2024, 10(3): 85-86.
[6] 蔡政忠. 氨磺必利、利培酮治疗精神分裂的疗效分析[J]. 医师在线, 2025(2): 79-81.
[7] 蔡政忠, 郑凤颦. 酒石酸美托洛尔片治疗心率过速出现几种精神病学观察[J]. 系统医学, 2024, 11(13): 12-13.
[8] 蔡政忠, 郑凤颦, 何维. 镇定药物与心理治疗在焦虑症患者康复中的比较分析[J]. 医学前沿, 2023(15): 90-91.
[9] 蔡政忠, 林嗣豪. 缬草粉与缬草精油治疗睡眠障碍患者的临床疗效[J]. 医师在线, 2024, 11(3): 32-33.
[10] 蔡政忠, 郑凤颦. 中草药雷公藤治疗难治性肥胖的研究进展[J]. 药物与人, 2023, 36(16): 131-133.
[11] 蔡政忠, 林嗣豪. 性成瘾患者采用泌乳激素治疗能有效降低性欲唤起[J]. 世界复合医学, 2024, 10(3): 137-138.